Upregulation of Annexin A1 Expression by Butyrate in Human Colon Adenocarcinoma Cells: Role of p53, NF-Y, and p38 Mitogen-Activated Protein Kinase

REFERENCES

• Bai, X. F., X. G. Ni, P. Zhao, S. M. Liu, H. X. Wang, B. Guo, L. P. Zhou, F. Liu, J. S. Zhang, K. Wang, Y. Q. Xie, Y. F. Shao, and X. H. Zhao. 2004. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J. Gastroenterol. 10:1466–1470.
   PubMedGoogle Scholar
• Benatti, P., V. Basile, D. Merico, L. I. Fantoni, E. Tagliafico, and C. Imbriano. 2008. A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res. 36:1415–1428.
   PubMedGoogle Scholar
• Bevilacqua, M. A., M. C. Faniello, B. Iovine, T. Russo, F. Cimino, and F. Costanzo. 2002. Transcription factor NF-Y regulates differentiation of CaCo-2 cells. Arch. Biochem. Biophys. 407:39–44.
   PubMedGoogle Scholar
• Cartharius, K., K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942.
   PubMed Web of Science ®Google Scholar
• D'Acquisto, F., A. Merghani, E. Lecona, G. Rosignoli, K. Raza, C. D. Buckley, R. J. Flower, and M. Perretti. 2007. Annexin 1 modulates T-cell activation and differentiation. Blood 109:1095–1102.
   PubMed Web of Science ®Google Scholar
• Daniel, C., O. Schroder, N. Zahn, T. Gaschott, and J. Stein. 2004. p38 MAPK signaling pathway is involved in butyrate-induced vitamin D receptor expression. Biochem. Biophys. Res. Commun. 324:1220–1226.
   PubMed Web of Science ®Google Scholar
• Davie, J. R. 2003. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133:2485S–2493S.
   PubMed Web of Science ®Google Scholar
• Djelloul, S., M. E. Forgue-Lafitte, B. Hermelin, M. Mareel, E. Bruyneel, A. Baldi, A. Giordano, E. Chastre, and C. Gespach. 1997. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products. FEBS Lett. 406:234–242.
   PubMed Web of Science ®Google Scholar
• Donnelly, S. R., and S. E. Moss. 1998. Functional analysis of the human annexin I and VI gene promoters. Biochem. J. 332:681–687.
   PubMedGoogle Scholar
• Gerke, V., C. E. Creutz, and S. E. Moss. 2005. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6:449–461.
   PubMed Web of Science ®Google Scholar
• Gerke, V., and S. E. Moss. 2002. Annexins: from structure to function. Physiol. Rev. 82:331–371.
   PubMed Web of Science ®Google Scholar
• Gui, C. Y., L. Ngo, W. S. Xu, V. M. Richon, and P. A. Marks. 2004. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. Proc. Natl. Acad. Sci. USA 101:1241–1246.
   PubMed Web of Science ®Google Scholar
• Guzmán-Aránguez, A., N. Olmo, J. Turnay, E. Lecona, P. Perez-Ramos, I. López de Silanes, and M. A. Lizarbe. 2005. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. J. Cell Biochem. 94:178–193.
   PubMed Web of Science ®Google Scholar
• Hannon, R., J. D. Croxtall, S. J. Getting, F. Roviezzo, S. Yona, M. J. Paul-Clark, F. N. Gavins, M. Perretti, J. F. Morris, J. C. Buckingham, and R. J. Flower. 2003. Aberrant inflammation and resistance to glucocorticoids in annexin 1−/− mouse. FASEB J. 17:253–255.
   PubMedGoogle Scholar
• Hirose, T., Y. Sowa, S. Takahashi, S. Saito, C. Yasuda, N. Shindo, K. Furuichi, and T. Sakai. 2003. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22:7762–7773.
   PubMed Web of Science ®Google Scholar
• Hoh, J., S. Jin, T. Parrado, J. Edington, A. J. Levine, and J. Ott. 2002. The p53MH algorithm and its application in detecting p53-responsive genes. Proc. Natl. Acad. Sci. USA 99:8467–8472.
   PubMed Web of Science ®Google Scholar
• Huang, W., S. Zhao, S. Ammanamanchi, M. Brattain, K. Venkatasubbarao, and J. W. Freeman. 2005. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280:10047–10054.
   PubMedGoogle Scholar
• Imbriano, C., A. Gurtner, F. Cocchiarella, S. Di Agostino, V. Basile, M. Gostissa, M. Dobbelstein, G. Del Sal, G. Piaggio, and R. Mantovani. 2005. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol. Cell. Biol. 25:3737–3751.
   PubMed Web of Science ®Google Scholar
• Isacke, C. M., R. A. Lindberg, and T. Hunter. 1989. Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids. Mol. Cell. Biol. 9:232–240.
   PubMed Web of Science ®Google Scholar
• Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377–4384.
   PubMed Web of Science ®Google Scholar
• Kim, S. W., H. J. Rhee, J. Ko, Y. J. Kim, H. G. Kim, J. M. Yang, E. C. Choi, and D. S. Na. 2001. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J. Biol. Chem. 276:15712–15719.
   PubMedGoogle Scholar
• Lopez-Conejo, T., N. Olmo, J. Turnay, J. Navarro, and A. Lizarbe. 1996. Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line. Int. J. Cancer 67:668–675.
   PubMedGoogle Scholar
• López de Silanes, I., N. Olmo, J. Turnay, G. González de Buitrago, P. Pérez-Ramos, A. Guzmán-Aránguez, M. García-Díez, E. Lecona, M. Gorospe, and M. A. Lizarbe. 2004. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells. Cancer Res. 64:4593–4600.
   PubMedGoogle Scholar
• Manni, I., G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276:5570–5576.
   PubMedGoogle Scholar
• Marutani, M., H. Tonoki, M. Tada, M. Takahashi, H. Kashiwazaki, Y. Hida, J. Hamada, M. Asaka, and T. Moriuchi. 1999. Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme. Cancer Res. 59:4765–4769.
   PubMedGoogle Scholar
• McMillan, L., S. K. Butcher, J. Pongracz, and J. M. Lord. 2003. Opposing effects of butyrate and bile acids on apoptosis of human colon adenoma cells: differential activation of PKC and MAP kinases. Br J. Cancer 88:748–753.
   PubMedGoogle Scholar
• Minucci, S., and P. G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat. Rev. Cancer 6:38–51.
   PubMed Web of Science ®Google Scholar
• Nakano, K., T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai. 1997. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:22199–22206.
   PubMed Web of Science ®Google Scholar
• Navarro, J. M., N. Olmo, J. Turnay, M. T. López-Conejo, and M. A. Lizarbe. 1997. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase in 5′-nucleotidase activity. Eur. J. Clin. Investig. 27:620–628.
   PubMedGoogle Scholar
• Olmo, N., J. Turnay, E. Lecona, M. Garcia-Diez, B. Llorente, A. Santiago-Gomez, and M. A. Lizarbe. 2007. Acquisition of resistance to butyrate induces resistance to luminal components and other types of stress in human colon adenocarcinoma cells. Toxicol. In Vitro 21:254–261.
   PubMedGoogle Scholar
• Omer, S., D. Meredith, J. F. Morris, and H. C. Christian. 2006. Evidence for the role of adenosine 5′-triphosphate-binding cassette (ABC)-A1 in the externalization of annexin 1 from pituitary folliculostellate cells and ABCA1-transfected cell models. Endocrinology 147:3219–3227.
   PubMedGoogle Scholar
• Parente, L., and E. Solito. 2004. Annexin 1: more than an anti-phospholipase protein. Inflamm. Res. 53:125–132.
   PubMed Web of Science ®Google Scholar
• Patton, K. T., H. M. Chen, L. Joseph, and X. J. Yang. 2005. Decreased annexin I expression in prostatic adenocarcinoma and in high-grade prostatic intraepithelial neoplasia. Histopathology 47:597–601.
   PubMedGoogle Scholar
• Perretti, M., and F. N. Gavins. 2003. Annexin 1: an endogenous anti-inflammatory protein. News Physiol. Sci. 18:60–64.
   PubMedGoogle Scholar
• Petrella, A., C. W. D'Acunto, M. Rodriquez, M. Festa, A. Tosco, I. Bruno, S. Terracciano, M. Taddei, L. G. Paloma, and L. Parente. 2008. Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: Role of Annexin A1. Eur. J. Cancer 44:740–749.
   PubMedGoogle Scholar
• Petrella, A., M. Festa, S. F. Ercolino, M. Zerilli, G. Stassi, E. Solito, and L. Parente. 2006. Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation. Cancer Biol. Ther. 5:643–647.
   PubMed Web of Science ®Google Scholar
• Rodrigo, J. P., J. M. Garcia-Pedrero, M. V. Gonzalez, M. P. Fernandez, C. Suarez, and A. Herrero. 2004. Expression of annexin A1 in normal and chronically inflamed nasal mucosa. Arch. Otolaryngol. Head Neck Surg. 130:211–215.
   PubMedGoogle Scholar
• Sandoval, J., J. L. Rodríguez, G. Tur, G. Serviddio, J. Pereda, A. Boukaba, J. Sastre, L. Torres, L. Franco, and G. López-Rodas. 2004. RNAPol-ChIP: a novel application of chromatin immunoprecipitation to the analysis of real-time gene transcription. Nucleic Acids Res. 32:e88.
   PubMed Web of Science ®Google Scholar
• Scheppach, W., and F. Weiler. 2004. The butyrate story: old wine in new bottles? Curr. Opin. Clin. Nutr. Metab. Care 7:563–567.
   PubMed Web of Science ®Google Scholar
• Shen, D., F. Nooraie, Y. Elshimali, V. Lonsberry, J. He, S. Bose, D. Chia, D. Seligson, H. R. Chang, and L. Goodglick. 2006. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum. Pathol. 37:1583–1591.
   PubMed Web of Science ®Google Scholar
• Solito, E., C. de Coupade, L. Parente, R. J. Flower, and F. Russo-Marie. 1998. Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ. 9:327–336.
   PubMedGoogle Scholar
• Solito, E., C. de Coupade, L. Parente, R. J. Flower, and F. Russo-Marie. 1998. IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine 10:514–521.
   PubMed Web of Science ®Google Scholar
• Tabe, Y., L. Jin, R. Contractor, D. Gold, P. Ruvolo, S. Radke, Y. Xu, Y. Tsutusmi-Ishii, K. Miyake, N. Miyake, S. Kondo, A. Ohsaka, I. Nagaoka, M. Andreeff, and M. Konopleva. 2007. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ. 14:1443–1456.
   PubMed Web of Science ®Google Scholar
• Turnay, J., N. Olmo, J. G. Gavilanes, J. Benítez, and M. A. Lizarbe. 1990. Establishment and characterization of a new human colon adenocarcinoma cell line: BCS-TC2. Cytotechnology 3:75–88.
   PubMedGoogle Scholar
• Vishwanatha, J. K., E. Salazar, and V. K. Gopalakrishnan. 2004. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 4:8.
   PubMed Web of Science ®Google Scholar
• Wang, K. L., T. T. Wu, E. Resetkova, H. Wang, A. M. Correa, W. L. Hofstetter, S. G. Swisher, J. A. Ajani, A. Rashid, S. R. Hamilton, and C. T. Albarracin. 2006. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin. Cancer Res. 12:4598–4604.
   PubMed Web of Science ®Google Scholar
• Wu, C. M., Y. S. Lee, T. H. Wang, L. Y. Lee, W. H. Kong, E. S. Chen, M. L. Wei, Y. Liang, and T. L. Hwang. 2006. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. Oncol. Rep. 15:57–64.
   PubMedGoogle Scholar
• Yonezawa, T., Y. Kobayashi, and Y. Obara. 2007. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell. Signal. 19:185–193.
   PubMed Web of Science ®Google Scholar
• Yun, J., H. D. Chae, T. S. Choi, E. H. Kim, Y. J. Bang, J. Chung, K. S. Choi, R. Mantovani, and D. Y. Shin. 2003. Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway. J. Biol. Chem. 278:36966–36972.
   PubMedGoogle Scholar
• Zhao, Y., S. Lu, L. Wu, G. Chai, H. Wang, Y. Chen, J. Sun, Y. Yu, W. Zhou, Q. Zheng, M. Wu, G. A. Otterson, and W. G. Zhu. 2006. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21Waf1/Cip1. Mol. Cell. Biol. 26:2782–2790.
   PubMed Web of Science ®Google Scholar